Gryphon Investors

Gryphon Investors is a San Francisco-based middle-market private equity firm known for a proactive, thesis-driven approach to building market-leading service organizations. Healthcare is one of its core verticals, with focus on Care Delivery and tech-enabled services. AI is not a dedicated thesis, and the firm’s identity is more operational private equity than tech investing. Specific AUM data is not provided in the input.

Check sizes are $25M+ at the growth stage, with control buyout structures common. Geographic deployment is primarily U.S., with a bias toward businesses where Gryphon’s operating playbook can drive structural margin expansion. Specific healthcare portfolio companies are not listed in the source data. Diligence is heavy on operational benchmarking, management assessment, and add-on M&A pipeline.

For most physician AI founders, Gryphon is not a near-term fit. The firm becomes relevant when a healthcare services business has crossed several million dollars in EBITDA and is ready for a control transaction with significant operational involvement. The right profile is the CEO of a multi-site clinical services company looking for a long-tenured PE partner to support a multi-year platform build.